CPT 81168 CCND1/IGH Reimbursement & Policy | OpenPayer

Summary & Overview

CPT 81168: CCND1/IGH (t(11;14)) Translocation Analysis, Technical Component

CPT code 81168 covers the technical laboratory procedure that detects the CCND1/IGH (t(11;14)) major breakpoint translocation, a genomic alteration commonly associated with mantle cell lymphoma. This molecular/cytogenetic assay is clinically significant because identification of the t(11;14) translocation supports diagnosis, risk stratification, and therapeutic planning for patients with suspected or confirmed lymphoid neoplasms. Nationally, utilization of targeted translocation testing influences downstream pathology workflows, resource allocation in clinical laboratories, and payer coverage decisions.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for CCND1/IGH testing, typical laboratory and site-of-service considerations, and the payer landscape relevant to molecular cytogenetic assays. The report also summarizes common modifiers used with laboratory technical services and highlights areas where policy language and coverage criteria can affect access and billing practices.

The publication provides practical benchmarks for laboratory service coding, a summary of payer coverage patterns where available, and clarity on how the test is positioned within laboratory service lines. Data not available in the input is identified explicitly when relevant.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare81168CPTmolecular-pathologycytogeneticsmantle-cell-lymphomatranslocation-analysislaboratory-technical-component

Billing Code Overview

CPT code 81168 describes a laboratory technical service that performs a major breakpoint translocation analysis for CCND1/IGH (t(11;14)), a chromosomal translocation associated with mantle cell lymphoma (MCL). The test is performed on specimens such as blood, formalin–fixed paraffin embedded tissue (FFPE), or bone marrow.

Service type: Molecular pathology / cytogenetic translocation analysis (technical component)

Typical site of service: Clinical laboratory or pathology laboratory

Clinical & Coding Specifications

Clinical Context

A 64-year-old male with progressive lymphadenopathy and cytopenias undergoes excisional lymph node biopsy. Pathology suggests a mature B‑cell neoplasm; flow cytometry is inconclusive for definitive subtyping. The treating hematologist-oncologist orders molecular testing for CCND1/IGH t(11;14) to confirm suspected mantle cell lymphoma (MCL). A laboratory technologist receives a formalin-fixed, paraffin-embedded (FFPE) tissue block and performs the technical component of a major breakpoint translocation analysis using fluorescence in situ hybridization (FISH) or another validated molecular method. The workflow includes specimen accessioning, slide preparation or nucleic acid extraction, hybridization or assay setup, signal detection and imaging, technical quality control, and generation of raw technical data. The laboratory analyst documents test run parameters, technical findings (e.g., percentage of nuclei with fusion signals), and transfers images/data to the sign-out pathologist for interpretation and clinical report generation. Billing for the technical processing of the CCND1/IGH translocation analysis is reported with 81168 when the lab performs the technical testing on specimens such as blood, FFPE tissue, or bone marrow.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting only the interpretation/reading (professional) component separate from the technical work (not for which describes the technical component).

CPT 81270: JAK2 Mutation Detection Laboratory Test

CPT-81330-SMPD1-GENETIC-VARIANT-DETECTION

CPT 81330: SMPD1 Gene Variant Detection

CPT-81271-HUNTINGTIN-GENE-HTT-EXPANDED-ALLELE-DETECTION

CPT 81271: Huntingtin (HTT) Gene Expanded Allele Detection

CPT-81283-IFNL3-RS12979860-GENOTYPING

CPT 81283: IFNL3 (rs12979860) Genotyping

CPT-81162-BRCA1-BRCA2-SEQUENCING-DELETION-DUPLICATION-ANALYSIS

CPT 81162: BRCA1 and BRCA2 Full Gene Sequencing and Deletion/Duplication Analysis

CPT-81350-UGT1A1-GENETIC-VARIANT-DETECTION-LAB-TECHNICAL

CPT 81350: UGT1A1 Genetic Variant Detection, Laboratory Technical Service

CPT-81326-PMP22-FAMILIAL-MUTATION-TESTING

CPT 81326: Targeted Familial Mutation Analysis, PMP22

CPT-81210-BRAF-MUTATION-DETECTION-TECHNICAL-ASSAY

CPT 81210: BRAF Mutation Detection, Technical Laboratory Assay

CPT-81252-GJB2-FULL-GENE-SEQUENCING

CPT 81252: Full Gene Sequencing of GJB2 (Connexin 26)

CPT-81363-HBB-GENE-DUPLICATION-DELETION-ANALYSIS

CPT 81363: HBB Gene Duplication and Deletion Analysis

Showing 1–10 of 199

81168

Taxonomy Code	Specialty	Notes
2080P0200X	Hematology & Hematology Oncology	Hematologist-oncologists order testing and interpret results in clinical context.
207RC0000X	Anatomic and Clinical Pathology	Pathologists interpret molecular pathology results and finalize reports.
207L00000X	Clinical Laboratory	Medical laboratory technologists and molecular technologists perform the technical assay.
207K00000X	Clinical Molecular Genetics Laboratory	Laboratories specializing in molecular diagnostics commonly perform translocation testing.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C83.1`	Mantle cell lymphoma	Primary disease indication for CCND1/IGH (t(11;14)) testing; molecular confirmation guides diagnosis.
`C85.9`	Non‑Hodgkin lymphoma, unspecified	Used when lymphoma subtype is not yet specified and translocation testing assists classification.
`C91.1`	Chronic lymphocytic leukemia of B‑cell type	Distinction from other B‑cell neoplasms may prompt translocation testing if morphology/phenotype is atypical.
`R59.0`	Localized enlarged lymph nodes	Initial presentation that leads to biopsy and subsequent molecular testing for lymphoma subtyping.
`D47.1`	Chronic lymphocytic leukemia/small lymphocytic lymphoma	Related B‑cell disorders where molecular testing may be part of differential diagnosis.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`88305`	Level IV surgical pathology, gross and microscopic examination	Performed on the biopsy specimen prior to molecular testing to establish morphology and direct ancillary testing.
`88342`	Immunohistochemistry, per specimen; initial single antibody stain	IHC for cyclin D1 or SOX11 may be performed before or alongside molecular testing to support MCL diagnosis.
`88271`	Flow cytometry, initial identification and quantification of cell surface markers	Flow cytometry is commonly performed on blood, bone marrow, or lymph node specimens to phenotype lymphoid populations prior to molecular testing.
`81229`	BCR-ABL1 (for comparison of translocation testing workflows)	Although a different target, cytogenetic/molecular translocation assays like `81229` share similar laboratory processes and may be performed in parallel in hematologic malignancy workups.
`88237`	FISH, each additional single probe/target	Used when additional FISH probes or loci are tested in the same specimen alongside CCND1/IGH analysis; supports comprehensive cytogenetic assessment.

OpenPayer